CN105461674A - 1(r)-(4-羟基苯)-5(s)-苯基吡喃及其制备方法和作为制备防治肿瘤药物的应用 - Google Patents
1(r)-(4-羟基苯)-5(s)-苯基吡喃及其制备方法和作为制备防治肿瘤药物的应用 Download PDFInfo
- Publication number
- CN105461674A CN105461674A CN201511015311.6A CN201511015311A CN105461674A CN 105461674 A CN105461674 A CN 105461674A CN 201511015311 A CN201511015311 A CN 201511015311A CN 105461674 A CN105461674 A CN 105461674A
- Authority
- CN
- China
- Prior art keywords
- methyl alcohol
- volume ratio
- mixed solution
- mixed
- methylene dichloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 title abstract 4
- 208000019065 cervical carcinoma Diseases 0.000 claims abstract description 17
- 206010041823 squamous cell carcinoma Diseases 0.000 claims abstract description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 264
- 239000011259 mixed solution Substances 0.000 claims description 132
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 108
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 72
- HWEZWCGDAIOGRO-NSHDSACASA-N (2S)-2-phenyl-2H-pyran Chemical compound C1(=CC=CC=C1)[C@H]1OC=CC=C1 HWEZWCGDAIOGRO-NSHDSACASA-N 0.000 claims description 49
- 239000007788 liquid Substances 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000010828 elution Methods 0.000 claims description 15
- 238000010898 silica gel chromatography Methods 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 238000010829 isocratic elution Methods 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 10
- 238000000926 separation method Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 239000006185 dispersion Substances 0.000 claims description 5
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- 210000004881 tumor cell Anatomy 0.000 abstract description 3
- LTMXQBYDTUQJGE-UHFFFAOYSA-N 3-phenylpentan-3-ylbenzene Chemical class C=1C=CC=CC=1C(CC)(CC)C1=CC=CC=C1 LTMXQBYDTUQJGE-UHFFFAOYSA-N 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 6
- 238000005457 optimization Methods 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000000452 restraining effect Effects 0.000 description 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000003211 Corylus maxima Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001263603 Stellera Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- FBTUMDXHSRTGRV-ALTNURHMSA-N zorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\NC(=O)C=1C=CC=CC=1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 FBTUMDXHSRTGRV-ALTNURHMSA-N 0.000 description 1
- 229960000641 zorubicin Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511015311.6A CN105461674B (zh) | 2015-12-31 | 2015-12-31 | 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511015311.6A CN105461674B (zh) | 2015-12-31 | 2015-12-31 | 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105461674A true CN105461674A (zh) | 2016-04-06 |
CN105461674B CN105461674B (zh) | 2018-11-02 |
Family
ID=55599890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511015311.6A Active CN105461674B (zh) | 2015-12-31 | 2015-12-31 | 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105461674B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861126A (zh) * | 2021-09-08 | 2021-12-31 | 新疆维吾尔自治区中药民族药研究所 | 高度氧化二萜及其制备方法和作为制备预防或/和治疗炎症的抗炎、抗菌药物中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142495A (zh) * | 1996-06-28 | 1997-02-12 | 中国人民解放军第二军医大学 | 一种新型血小板激活因子拮抗剂及其制备方法 |
US20060276536A1 (en) * | 2004-02-12 | 2006-12-07 | Vander Jagt David L | Cancer treatment using curcumin derivatives |
WO2011022502A1 (en) * | 2009-08-18 | 2011-02-24 | Georgetown University | Boronic acid compositions and methods related to cancer |
-
2015
- 2015-12-31 CN CN201511015311.6A patent/CN105461674B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142495A (zh) * | 1996-06-28 | 1997-02-12 | 中国人民解放军第二军医大学 | 一种新型血小板激活因子拮抗剂及其制备方法 |
US20060276536A1 (en) * | 2004-02-12 | 2006-12-07 | Vander Jagt David L | Cancer treatment using curcumin derivatives |
WO2011022502A1 (en) * | 2009-08-18 | 2011-02-24 | Georgetown University | Boronic acid compositions and methods related to cancer |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861126A (zh) * | 2021-09-08 | 2021-12-31 | 新疆维吾尔自治区中药民族药研究所 | 高度氧化二萜及其制备方法和作为制备预防或/和治疗炎症的抗炎、抗菌药物中的应用 |
CN113861126B (zh) * | 2021-09-08 | 2024-03-12 | 新疆维吾尔自治区中药民族药研究所 | 高度氧化二萜及其制备方法和作为制备预防或/和治疗炎症的抗炎、抗菌药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105461674B (zh) | 2018-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101637486B (zh) | 白芷香豆素提取物、制备方法及其质量检测方法 | |
CN102641317B (zh) | 金鸡菊提取物及其在制备抗糖尿病药物中的应用 | |
Lee et al. | Anti‐Inflammatory Effects of Bangpungtongsung‐San, a Traditional Herbal Prescription | |
CN102702071A (zh) | 一种天仙子中新化合物和制备方法及应用 | |
CN105111263A (zh) | 从荠菜中分离纯化的黄酮类化合物及其制备方法和用途 | |
US8377895B2 (en) | Cyclin-dependent protein kinases inhibitors of Scutellaria flavonoid organic amine derivatives, synthesis and use thereof | |
CN105461674A (zh) | 1(r)-(4-羟基苯)-5(s)-苯基吡喃及其制备方法和作为制备防治肿瘤药物的应用 | |
CN101028322B (zh) | 毛裂蜂斗菜提取物用于制备防治肿瘤疾病药物的用途 | |
CN105503541A (zh) | 1(s)-(4-羟基苯)-5-苯基-1-戊醇及其制备方法和作为制备防治肿瘤药物的应用 | |
CN107840836A (zh) | 淫羊藿素k及其制备方法和在药物上的应用 | |
CN103191143B (zh) | 一种强心苷化合物的用途 | |
CN101284835B (zh) | 双倍半萜内酯类化合物及其制备方法和应用 | |
CN106551925A (zh) | 油桐种壳精制木脂素提取物、制备方法及其应用 | |
CN100590119C (zh) | 一种抗肿瘤化合物红波罗花碱a及其制备方法和应用 | |
CN101747190A (zh) | 没药烷型倍半萜类化合物及其制备方法和应用 | |
CN106580937B (zh) | 月腺大戟素a的制备方法及其在制备乳腺癌药物中的应用 | |
CN101318946B (zh) | 化合物二聚兔耳风萜a及其制备方法和应用 | |
CN105732380B (zh) | 一种二苯庚烷化合物及其制备方法和应用 | |
CN104107199A (zh) | 骆驼蓬总生物碱的制备方法 | |
Tan et al. | Integrated analysis of topoisomerase I inhibitors from flavonoids of Scutellaria baicalensis Georgi using bioaffinity ultrafiltration UPLC-TripleTOF MS/MS, molecular docking and target-based multiple complex networks | |
Hu et al. | Current status of research on endophytes of traditional Tibetan medicinal plant and their metabolites | |
CN104257641B (zh) | 一种c36多炔类化合物及其制备和应用 | |
CN105541858A (zh) | Xanthone类化合物及其制备方法、组合物和用途 | |
CN104610207B (zh) | 大黄栀子素a及其制备方法和在药物上的应用 | |
CN104523675A (zh) | 莪术环氧酮在制备防治银屑病药物或食品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: No. 9, Xinmin Road, Tianshan District, Urumqi, the Xinjiang Uygur Autonomous Region Applicant after: Xinjing Vygur Autonomous Region Chinese Medicine and Ethnic Medicine Research In Address before: No. 9, Xinmin Road, Shuimogou District, Urumqi, the Xinjiang Uygur Autonomous Region Applicant before: Xinjing Vygur Autonomous Region Chinese Medicine and Ethnic Medicine Research In |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210729 Address after: 830023 No. 61, shaping West Street, industrial park, Toutunhe District, Urumqi City, Xinjiang Uygur Autonomous Region Patentee after: XINJIANG BIOCHEMICAL PHARMACEUTICAL Co.,Ltd. Address before: 830002 No.9 Xinmin Road, Tianshan District, Urumqi, Xinjiang Uygur Autonomous Region Patentee before: Xinjiang Uygur Autonomous Region Institute of traditional Chinese Medicine |
|
TR01 | Transfer of patent right |